Found: 46
Select item for more details and to access through your institution.
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. E353, doi. 10.1002/ajh.26274
- By:
- Publication type:
- Article
Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. E24, doi. 10.1002/ajh.24951
- By:
- Publication type:
- Article
Recent Advances in the Treatment of Peripheral T‐Cell Lymphoma.
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1039, doi. 10.1634/theoncologist.2017-0524
- By:
- Publication type:
- Article
Factors associated with efficacy of botulinum toxin a injections in primary axillary hyperhidrosis: A retrospective study of ninety patients.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15620
- By:
- Publication type:
- Article
An International, Randomized, Double Blind Trial Comparing Denosumab With Zoledronic Acid (ZA) for the Treatment of Bone Disease in Patients (Pts) With Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e27, doi. 10.1016/j.clml.2017.03.047
- By:
- Publication type:
- Article
Quadri-lineage disease involving nodal B-cell marginal zone lymphoma, high-grade B-cell lymphoma, Kaposi's syndrome, and acute myeloid leukemia.
- Published in:
- Clinical Case Reports, 2016, v. 4, n. 1, p. 39, doi. 10.1002/ccr3.393
- By:
- Publication type:
- Article
Meningeal involvement in multiple myeloma.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 10, p. 1, doi. 10.1038/s41408-021-00555-8
- By:
- Publication type:
- Article
Inflammatory disorders associated with trisomy 8‐myelodysplastic syndromes: French retrospective case‐control study.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 1, p. 63, doi. 10.1111/ejh.13174
- By:
- Publication type:
- Article
Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 2, p. 165, doi. 10.1111/ejh.13088
- By:
- Publication type:
- Article
Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-Azacytidine.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 1, p. 81, doi. 10.1111/ejh.12294
- By:
- Publication type:
- Article
Filgrastim prophylaxis in elderly cancer patients in the real-life setting: a French multicenter observational study, the TULIP study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Primary cutaneous indolent B-cell lymphomas – a retrospective multicenter analysis and a review of literature.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 10, p. 1361, doi. 10.1080/0284186X.2021.1956689
- By:
- Publication type:
- Article
Leucémie lymphoïde chronique avec t(14;18) et trisomie 12 : un cas clinique.
- Published in:
- Annales de Biologie Clinique, 2018, v. 76, n. 4, p. 445, doi. 10.1684/abc.2018.1353
- By:
- Publication type:
- Article
Le syndrome de Shwachman-Diamond : à propos d'un cas.
- Published in:
- Annales de Biologie Clinique, 2018, v. 76, n. 4, p. 435, doi. 10.1684/abc.2018.1358
- By:
- Publication type:
- Article
Lymphome lymphoplasmocytaire ou myélome multiple : quand les immunoglobulines induisent en erreur.
- Published in:
- Annales de Biologie Clinique, 2018, v. 76, n. 4, p. 451, doi. 10.1684/abc.2018.1357
- By:
- Publication type:
- Article
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 535, doi. 10.1111/bjh.18193
- By:
- Publication type:
- Article
Response to vaccination against SARS‐CoV‐2 in 168 patients with Waldenström macroglobulinaemia: A French Innovative Leukaemia Organization study.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 4, p. 424, doi. 10.1111/bjh.18055
- By:
- Publication type:
- Article
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real‐life study.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 2, p. 336, doi. 10.1111/bjh.17539
- By:
- Publication type:
- Article
Characterisation of a new clinical presentation of chronic lymphocytic leukaemia: symptomatic bronchial involvement, a study from the FILO group.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. e126, doi. 10.1111/bjh.15966
- By:
- Publication type:
- Article
Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 1, p. 146, doi. 10.1111/bjh.15718
- By:
- Publication type:
- Article
Bendamustine and rituximab in elderly patients with low‐tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 76, doi. 10.1111/bjh.15513
- By:
- Publication type:
- Article
Efficacy and safety of pegylated-interferon α-2a in myelofibrosis: a study by the FIM and GEM French cooperative groups.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 6, p. 783, doi. 10.1111/bjh.12459
- By:
- Publication type:
- Article
High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R- NIMP GOELAMS study.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 2, p. 240, doi. 10.1111/bjh.12379
- By:
- Publication type:
- Article
Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Retacrit®, Biosimilar of Epoetin Alfa, in Chemotherapy-Induced Anemia in Routine Practice: Impact of Iron Supplementation.
- Published in:
- Oncology, 2022, v. 100, n. 10, p. 519, doi. 10.1159/000522069
- By:
- Publication type:
- Article
Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 5, p. 991, doi. 10.1111/bcp.14211
- By:
- Publication type:
- Article
IgM k multiple myeloma with monoclonal surface immunoglobulin expression.
- Published in:
- 2018
- By:
- Publication type:
- case study
Long‐term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2233, doi. 10.1111/bjh.19409
- By:
- Publication type:
- Article
Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: review.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 987, doi. 10.1007/s00277-021-04419-w
- By:
- Publication type:
- Article
Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 12, p. 2391, doi. 10.1007/s00277-018-3468-5
- By:
- Publication type:
- Article
R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Real‐life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study.
- Published in:
- EJHaem, 2024, v. 5, n. 1, p. 55, doi. 10.1002/jha2.828
- By:
- Publication type:
- Article
Real‐world clinical effectiveness and safety of CT‐P10 in patients with diffuse large B‐cell lymphoma: An observational study in Europe.
- Published in:
- EJHaem, 2023, v. 4, n. 1, p. 45, doi. 10.1002/jha2.593
- By:
- Publication type:
- Article
Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 976, doi. 10.1002/hon.3044
- By:
- Publication type:
- Article
Does early disease progression predict survival after first line‐treatment of Waldenström macroglobulinemia?
- Published in:
- Hematological Oncology, 2022, v. 40, n. 3, p. 400, doi. 10.1002/hon.2996
- By:
- Publication type:
- Article
The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 7175, doi. 10.1002/cam4.5459
- By:
- Publication type:
- Article
Impact of the relative dose intensity on survival of patients with high‐risk myelodysplastic syndromes treated with Azacitidine.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 5, p. 2188, doi. 10.1002/cam4.2121
- By:
- Publication type:
- Article
Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 2241, doi. 10.2147/CMAR.S138661
- By:
- Publication type:
- Article
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51264-2
- By:
- Publication type:
- Article
Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antigen Count on Target-Mediated Elimination of Rituximab in Patients with Chronic Lymphocytic Leukemia: A Study of FILO Group.
- Published in:
- 2017
- By:
- Publication type:
- journal article